New Market Research Reports of Egg Phosphatidylcholine Market Expected to Reach Worth $12.2 Million by 2020

San Francisco, CA, August 20, 2014 --(PR.com)-- The global market for egg phosphatidylcholine is expected to reach USD 12.2 million by 2020, according to a new study by Grand View Research, Inc. Egg phosphatidylcholine demand is expected to rise on account of its choline content which is an essential nutrient in daily diet. In addition, increasing occurrence of diseases such as Alzheimer’s and memory loss for population aged over 65 years is expected to trigger the demand for egg phosphatidylcholine in their treatment.

Dietetic supplements were the largest application segment accounting for USD 5.7 million of egg phosphatidylcholine market revenue in 2013. Increasing awareness regarding consumption of food with high nutritional content is expected to boost the demand for egg phosphatidylcholine over the forecast period. Egg phosphatidylcholine is also used in pharmaceutical applications and accounted for over USD 1.2 million of market revenue in 2013.

The report “Egg Phosphatidylcholine Market Analysis By Application (Cosmetics, Pharmaceutical, Dietary Supplements) And Segment Forecasts To 2020,” is available now to Grand View Research customers and can also be purchased directly at

http://www.grandviewresearch.com/industry-analysis/egg-phosphatidylcholine-market

Further key findings from the study suggest:
• Dietary supplements were the fastest growing application segment in the egg phosphatidylcholine market, at an estimated CAGR of 5.6% from 2014 to 2020.
• Cosmetics were the second largest application segment for egg phosphatidylcholine, with market revenue expected to exceed USD 2.1 million by 2020, growing at a CAGR of 5.0% from 2014 to 2020. The dominance of cosmetics in the market can be attributed to increasing concerns regarding health and hygiene coupled with changing environmental patterns. In addition, increasing awareness in the youth regarding use of cosmetic products on the basis of quality is expected to further augment the demand for egg phosphatidylcholine.
• Europe was the largest market for egg phosphatidylcholine, with revenue USD 2.9 million in 2013 owing to existence of a strong market for cosmetics due to high consumer awareness. Asia Pacific is expected to witness fastest growth, at an estimated CAGR of 10.2% from 2014 to 2020 due to increasing demand from various application markets.
• Key Companies in the market include Nutrasal Inc, Avanti Polar Lipids Inc, Lipoid, Natural Factors, Kewpie Corporation, NOF America Corporation, and Jena Bioscience GmbH.

For the purpose of this study, Grand View Research has segmented the global egg phosphatidylcholine market on the basis of application and region:

• Egg Phosphatidylcholine Applications Outlook (Revenue, USD Million, 2012 - 2020)
• Cosmetics
• Pharmaceuticals
• Dietetic Supplements
• Egg Phosphatidylcholine Regional Outlook (Revenue, USD Million, 2012 - 2020)
• North America
• Europe
• Asia Pacific
• RoW

About Grand View Research

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit www.grandviewresearch.com.